James C. Graziano

Mr. James C. Graziano

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2023 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
LNLuke Nyakarahuka
Luke Nyakarahuka
SWShannon Whitmer
Shannon Whitmer
JKjohn david klena
john david klena
SBStephen Balinandi
Stephen Balinandi
ETEmir Talundzic
Emir Talundzic
TSTrevor Shoemaker
Trevor Shoemaker
: Rift Valley fever (RVF) is a zoonotic disease of public health and economic importance. Uganda has reported sporadic outbreaks of RVF in both humans and animals across the country, especially in the southwestern part of the “cattle corridor” through an established viral hemorrhagic fever surveillance system. We report 52 human cases of laboratory-confirmed RVF from 2017 to 2020. The case fatality rate was 42%. Among those infected, 92% were males and 90% were adults (≥ 18 years). Clinical symptoms were characterized by fever (69%), unexplained bleeding (69%), headache (51%), abdominal pain (49%), and nausea and vomiting (46%). Most of the cases (95%) originated from central and western districts that are part of the cattle corridor of Uganda, where the main risk factor was direct contact with livestock (P = 0.009). Other predictors of RVF positivity were determined to be male gender (P = 0.001) and being a butcher (P = 0.04). Next-generation sequencing identified the predominant Ugandan clade as Kenya-2, observed previously across East Africa. There is need for further investigation and research into the effect and spread of this neglected tropical disease in Uganda and the rest of Africa. Control measures such as promoting vaccination and limiting animal–human transmission could be explored to reduce the impact of RVF in Uganda and globally.

22 April 2024 in Viruses
Verified
Journal Article
Open access
PDF file
BABrian R. Amman
Brian R. Amman
AKAlusine H. Koroma
Alusine H. Koroma
ASAmy Schuh
Amy Schuh
ICImmah Conteh
Immah Conteh
TSTara Kathleen Sealy
Tara Kathleen Sealy
ALAIAH LEBBIE
AIAH LEBBIE
Sosuga virus (SOSV), a rare human pathogenic paramyxovirus, was first discovered in 2012 when a person became ill after working in South Sudan and Uganda. During an ecological investigation, several species of bats were sampled and tested for SOSV RNA and only one species, the Egyptian rousette bat (ERBs; Rousettus aegyptiacus), tested positive. Since that time, multiple other species have been sampled and ERBs in Uganda have continued to be the only species of bat positive for SOSV infection. Subsequent studies of ERBs with SOSV demonstrated that ERBs are a competent host for SOSV and shed this infectious virus while exhibiting only minor infection-associated pathology. Following the 2014 Ebola outbreak in West Africa, surveillance efforts focused on discovering reservoirs for zoonotic pathogens resulted in the capture and testing of many bat species. Here, SOSV RNA was detected by qRT-PCR only in ERBs captured in the Moyamba District of Sierra Leone in the central region of the country. These findings represent a substantial range extension from East Africa to West Africa for SOSV, suggesting that this paramyxovirus may occur in ERB populations throughout its sub-Saharan African range.

8 June 2025 in Antiviral Research
Verified
Journal Article
Open access
SKShannon Kirejczyk
Shannon Kirejczyk
ASAmy Schuh
Amy Schuh
BABrian R. Amman
Brian R. Amman
JGJonathan C. Guito
Jonathan C. Guito
TSTara K. Sealy
Tara K. Sealy
JTJonathan Towner
Jonathan Towner
To investigate the antiviral innate immune responses of natural reservoir bats, we conducted a histopathological analysis of Egyptian rousettes (Rousettus aegyptiacus) experimentally infected with either of two divergent RNA viruses they naturally host, Marburg virus (MARV; family Filoviridae) and Kasokero virus (KASV; family Nairoviridae). Bats were serially euthanized at similar post-infection time points and tissue-based analyses focused on the liver, the primary target for both viruses. At 3 days post-infection (DPI), in situ hybridization (ISH) signal for replicating MARV was 300x less evident than that of KASV, with little immune cell recruitment and localized interferon (IFN)-stimulated responses suggesting a tendency towards superb virus replication control and non-cytolytic viral clearance. By comparison, an early burst of hepatocellular KASV replication correlated with robust, tissue-wide IFN-stimulated responses, mononuclear phagocyte apoptosis, targeted natural killer (NK) and/or natural killer T (NKT) cell responses and localized cytokine induction, demonstrating the capacity to swiftly establish an antiviral state. The distinctive lack of IFN stimulated gene 15 and MARV RNA hepatocellular co-localization in a single MARV-infected bat with overt hepatitis suggests a fine-tuned role for IFN antagonism in Egyptian rousettes, and hints at how MARV-IFN pathway interactions might influence the evolution, transmission and maintenance of orthomarburgviruses in nature, whereas KASV is less adaptable to this vertebrate host. This work augments our understanding of bat immunology and suggests certain co-evolutionary relationships between bats and viruses. These defenses may be more broadly applicable to other viruses circulating in Egyptian rousettes and likely to other bat-virus relationships.

24 July 2023 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
ASAmy Schuh
Amy Schuh
BABrian R. Amman
Brian R. Amman
JGJonathan C. Guito
Jonathan C. Guito
JGJames C. Graziano
James C. Graziano
TSTara Kathleen Sealy
Tara Kathleen Sealy
JTJonathan Towner
Jonathan Towner
Background: The human-pathogenic Kasokero virus (KASV) circulates in an enzootic transmission cycle between Egyptian rousette bats (ERBs; Rousettus aegyptiacus) and their argasid tick ectoparasites, Ornithodoros (Reticulinasus) faini. Although tick salivary gland components have been shown to potentiate virus infection in vertebrate non-reservoirs (i.e. incidental hosts or small animal models of disease), there is a lack of information on the effect of tick salivary gland components on viral infection and shedding in vertebrate reservoirs. Methods: To determine the impact of tick salivary gland components on KASV infection and shedding in ERBs, KASV loads were quantified in blood, oral swab, rectal swab, and urine specimens collected daily through 18 days post inoculation from groups of ERBs intradermally inoculated with KASV or KASV + O. (R.) faini tick salivary gland extract (SGE). Results: Bats inoculated with KASV + tick SGE had significantly lower peak and cumulative KASV viremias and rectal shedding loads compared to bats inoculated with KASV only. Conclusions: We report for the first time to our knowledge that tick salivary gland components dampen arbovirus infection and shedding in a vertebrate reservoir. This study advances our understanding of biological factors underlying arbovirus maintenance in nature. Graphical

23 September 2025 in Journal of Virology
Verified
Journal Article
Open access
JEJessica A. Elbert
Jessica A. Elbert
ASAmy Schuh
Amy Schuh
BABrian R. Amman
Brian R. Amman
JGJonathan C. Guito
Jonathan C. Guito
JGJames C. Graziano
James C. Graziano
JTJonathan Towner
Jonathan Towner
Viral coinfections and their impact on long-term immunity represent an understudied area in disease ecology and infectious disease research. Coinfections can influence the host’s susceptibility to future infections, alter host and pathogen population dynamics, modify infection and shedding patterns, impose evolutionary pressures, and affect the risk of zoonotic spillover. Egyptian rousette bats (ERB; Rousettus aegyptiacus ; common name: Egyptian rousettes) are a natural reservoir host for Marburg virus (MARV) and Ravn virus (RAVV), as well as a vertebrate reservoir for Kasokero virus (KASV) and a putative reservoir for Sosuga virus (SOSV). Viral coinfections have been documented in numerous free-ranging bat species as well as ERBs, raising questions about how these interactions influence immune responses, viral shedding, and pathogen maintenance within the natural host population. This is particularly critical given the genetic diversity among co-circulating viral species (e.g., MARV and RAVV) and the potential implications for the development of protective immunity and subsequent viral inoculation outcomes. In this study, ERBs previously infected with MARV alone or KASV + MARV were inoculated approximately 8 months later with homotypic (MARV) or heterotypic (RAVV) orthomarburgvirus isolates. The results demonstrated no viral replication or shedding post-inoculation, and all bats displayed strong secondary immune responses consistent with sterilizing immunity. These findings suggest that both MARV monoinfection and KASV + MARV coinfection confer robust protection against reinfection, regardless of the viral isolate. This research enhances our understanding of immune responses during viral coinfections in bats and their potential role in mitigating zoonotic pathogen spillover. IMPORTANCE: Long-term immunity elicited in bats during coinfection (i.e., simultaneous infection) with viruses they naturally host is not well understood. These interactions could affect susceptibility to subsequent reinfection and pathogen spread. Egyptian rousette bats, natural hosts for several pathogenic zoonotic viruses, including Marburg and Kasokero viruses, can be found multiply infected in the wild, but the immune consequences of being coinfected remain unclear. Here, bats previously infected with either Marburg virus alone or with both Kasokero and Marburg viruses were later challenged with Marburg virus or the related Ravn virus. No reinoculated bats showed signs of virus replication, and all mounted strong immune responses. These results suggest that this coinfection combination still provides robust protection against reinfection, even with diverse orthomarburgviruses. This study helps improve our understanding of how bats manage viral coinfections and may inform how these interactions influence zoonotic spillover risk.